UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$488M |
| 2 |
NXP Semiconductors
NXPI
|
+$484M |
| 3 |
JPMorgan Chase
JPM
|
+$429M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$426M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$755M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$419M |
| 4 |
PepsiCo
PEP
|
+$387M |
| 5 |
Meta Platforms (Facebook)
META
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.14% |
| 2 | Financials | 7.54% |
| 3 | Healthcare | 5.64% |
| 4 | Industrials | 5.09% |
| 5 | Consumer Discretionary | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6601
Allot
ALLT
$383M
| $14K | ﹤0.01% |
2,659
-11,527
| -81% | -$61.4K |
|
6602
ARK Web x.0 ETF
ARKW
$1.76B
| $14K | ﹤0.01% |
276
-2,050
| -88% | -$104K |
|
6603
Bridgford Foods
BRID
$56.5M
| $14K | ﹤0.01% |
948
-442
| -32% | -$7.43K |
|
6604
iShares Yield Optimized Bond ETF
BYLD
$448M
| $14K | ﹤0.01% |
+582
| New | +$14.3K |
|
6605
Ellomay Capital Ltd
ELLO
$271M
| $14K | ﹤0.01% |
1,608
| – | – |
|
|
FGNX
6606
FG Nexus Inc
FGNX
$38.7M
| $14K | ﹤0.01% |
16
-1
| -6% | -$874 |
|
6607
Kamada
KMDA
$419M
| $14K | ﹤0.01% |
2,981
+2,681
| +894% | +$14K |
|
6608
Lakeland Industries
LAKE
$119M
| $14K | ﹤0.01% |
+1,113
| New | +$15.1K |
|
6609
Mueller Industries
MLI
$15.2B
| $14K | ﹤0.01% |
2,076
-21,404
| -91% | -$162K |
|
|
MTR
6610
Mesa Royalty Trust
MTR
$5.33M
| $14K | ﹤0.01% |
931
+8
| +0.9% | +$131 |
|
6611
Natural Alternatives International
NAII
$14.9M
| $14K | ﹤0.01% |
1,291
-733
| -36% | -$8.23K |
|
6612
Orion Group Holdings
ORN
$418M
| $14K | ﹤0.01% |
2,083
+248
| +14% | +$1.78K |
|
6613
RBB Bancorp
RBB
$455M
| $14K | ﹤0.01% |
536
+268
| +100% | +$7.11K |
|
|
RDHL
6614
Redhill Biopharma
RDHL
$3.68M
| $14K | ﹤0.01% |
3
+1
| +50% | +$5.76K |
|
6615
SCYNEXIS
SCYX
$52M
| $14K | ﹤0.01% |
129
+109
| +545% | +$15K |
|
6616
Invesco S&P 500 GARP ETF
SPGP
$2.3B
| $14K | ﹤0.01% |
300
-1,816
| -86% | -$87.5K |
|
6617
STAAR Surgical
STAA
$1.21B
| $14K | ﹤0.01% |
941
-2,304
| -71% | -$36K |
|
6618
Sterling Infrastructure
STRL
$16.7B
| $14K | ﹤0.01% |
1,185
-57,397
| -98% | -$758K |
|
6619
Tonix Pharmaceuticals
TNXP
$192M
| – | – |
0
| – | – |
|
6620
PUT
Travelers Companies
TRV
$80.2B
| $14K | ﹤0.01% |
+100
| New | +$14K |
|
6621
Veracyte
VCYT
$3.8B
| $14K | ﹤0.01% |
2,500
+751
| +43% | +$4.65K |
|
|
VRNA
6622
DELISTED
Verona Pharma
VRNA
| $14K | ﹤0.01% |
703
+702
| +70,200% | +$10.1K |
|
|
YARW
6623
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| – | – |
0
| – | – |
|
|
WORX
6624
DELISTED
SCWORX CORP NEW
WORX
| $14K | ﹤0.01% |
7
-2
| -22% | -$6.3K |
|
6625
Zevra Therapeutics
ZVRA
$686M
| $14K | ﹤0.01% |
104
+56
| +117% | +$5.42K |
|
Similar funds
UBS Group's Q1 2018 Portfolio in Review
As of Q1 2018, UBS Group held 8,641 positions worth $232B, down 4.8% from $243B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $8.61B in Q1 2018, closing 751 positions and reducing 3,579 holdings. Its most notable exit was CalAtlantic Group, Inc., an estimated $60.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Nutrien worth $56.3M.
- UBS Group's largest Q1 2018 buy was Nutrien: 1,191,668 shares worth $56.3M.
- UBS Group added most to Comcast in Q1 2018, an estimated $488M increase.
- UBS Group's biggest Q1 2018 reduction was UBS Group, cutting an estimated $755M.
- UBS Group fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $60.8M.
- UBS Group's ten largest holdings make up 15% of its $232B portfolio in Q1 2018.
- UBS Group opened 725 new positions and closed 751 in Q1 2018.
- UBS Group's portfolio value fell 4.8% quarter-over-quarter to $232B.
Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.